TNFSF10 and cardiovascular disorder: Several clinical studies have shown that reduced TRAIL levels are associated with poor prognosis in patients with acute myocardial infarction or heart failure, suggesting that TRAIL has predictive effects in cardiovascular diseases [11,12,13].